GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Median PS Value

Sinopharm Tech Holdings (HKSE:08156) Median PS Value : HK$6.27 (As of May. 27, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Sinopharm Tech Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.255. Sinopharm Tech Holdings's 10-Year median PS Ratio is 24.5882. Therefore, the Median PS Value for today is HK$6.27.

As of today (2024-05-27), Sinopharm Tech Holdings's share price is HK$0.11. Sinopharm Tech Holdings's Median PS Value is HK$6.27. Therefore, Sinopharm Tech Holdings's Price to Median PS Value for today is 0.02.

The historical rank and industry rank for Sinopharm Tech Holdings's Median PS Value or its related term are showing as below:

HKSE:08156' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.02   Med: 0.3   Max: 2.63
Current: 0.02

During the past 13 years, the highest Price to Median PS Value of Sinopharm Tech Holdings was 2.63. The lowest was 0.02. And the median was 0.30.

HKSE:08156's Price-to-Median-PS-Value is ranked better than
99.81% of 1028 companies
in the Software industry
Industry Median: 0.965 vs HKSE:08156: 0.02

Sinopharm Tech Holdings Median PS Value Historical Data

The historical data trend for Sinopharm Tech Holdings's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Median PS Value Chart

Sinopharm Tech Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.82 26.73 11.50 5.88 6.01

Sinopharm Tech Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.29 3.22 6.01 5.75 6.27

Competitive Comparison of Sinopharm Tech Holdings's Median PS Value

For the Software - Application subindustry, Sinopharm Tech Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's Price-to-Median-PS-Value Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's Price-to-Median-PS-Value falls into.



Sinopharm Tech Holdings Median PS Value Calculation

Sinopharm Tech Holdings's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.255*24.5882
=6.27

10-Year Median PS Ratio is 24.5882.
Sinopharm Tech Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.255.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopharm Tech Holdings  (HKSE:08156) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Sinopharm Tech Holdings's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.11/6.27
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopharm Tech Holdings Median PS Value Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings (HKSE:08156) Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines